Our MM patients who experienced VTE had a higher disease burden at diagnosis, evidenced by lower Hb levels, reduced serum albumin, elevated β2-microglobulin, hypercalcemia, and increased lactate dehydrogenase (LDH) levels. The gene discussed is GSTM1; the disease is hypercalcemia disease.